A pill made to treat one of the deadliest cancers was already setting high expectations after its approval in August . But when used in combination with chemo, it could revolutionize treatment, new data suggests.

Clinical trials show the combination is not only stopping pancreatic cancer tumors from growing and spreading — it can eliminate them entirely.

“This is the closest to cure,” said oncologist Dr. Wungki Park, when presenting the findings. “We’ve never seen such a thing.”

Previous research on the drug, daraxonrasib (sold as Rasonque), showed incredible promise. The drug alone was shown to double survival time for pancreatic cancer, a…

Read the full article at NYPOST.COM